Worcestershire, United Kingdom

Ann Logan


Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 49(Granted Patents)


Location History:

  • Worcester, GB (2003)
  • Worcestershire, GB (1999 - 2011)

Company Filing History:


Years Active: 1999-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ann Logan: Pioneering Neuronal Regeneration

Introduction:

Ann Logan, a trailblazing inventor hailing from Worcestershire, GB, is making waves in the field of biomedical science with her groundbreaking contributions to neuronal regeneration. With a total of three patents to her name, Ann Logan's work is revolutionizing the way we approach central nervous system (CNS) injuries and neurodegenerative diseases.

Latest Patents:

One of Ann Logan's latest patents focuses on neuron regeneration, introducing a gene silencing molecule designed to down-regulate the expression of a gene encoding a peptide involved in the Rho-A inhibitory pathway. This innovation aims to promote neuron survival and axon regeneration within the CNS, offering new possibilities for enhancing neural survival and promoting axonal growth.

Another patent by Ann Logan delves into compositions and methods for delivering agents that aid in neuronal regeneration and survival. This patent features devices for delivering DNA encoding neurotrophic and anti-fibrotic agents, providing novel approaches for treating CNS and peripheral nervous system injuries. The invention also explores the use of targeting agents to enhance neuronal survival and regeneration.

Career Highlights:

Throughout her career, Ann Logan has made significant contributions to the field of neuroscience and regenerative medicine. She has worked with reputable organizations such as The Whittier Institute for Diabetes & Endocrinology, where her innovative spirit has flourished. Ann Logan's expertise in neuronal regeneration has led to impactful advancements in the treatment of CNS injuries.

Collaborations:

Ann Logan has collaborated with esteemed professionals in the field, including Andrew J. Baird and Martin Berry. These collaborations have enriched her research endeavors and fostered a collaborative spirit focused on advancing the frontiers of neuronal regeneration. By working alongside talented individuals, Ann Logan has been able to bring her inventive ideas to fruition and make a lasting impact on the scientific community.

Conclusion:

In conclusion, Ann Logan's inventive genius and dedication to advancing neuronal regeneration are paving the way for transformative treatments in the realm of neurodegenerative diseases and CNS injuries. Her patents stand as a testament to her unwavering commitment to innovation, and her collaborations highlight the power of teamwork in driving scientific progress forward. Ann Logan's pioneering work continues to inspire and shape the future of regenerative medicine, offering hope for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…